Evaluation of serum biomarkers for patients at increased risk of stroke

Keyphrases

• Tissue Inhibitor of metalloproteinase-1 (TIMP-1) 100%
• Matrix metalloproteinase-1 (MMP-1) 100%
• Plaque 100%
• Serum Biomarkers 100%
• Stroke Risk 100%
• Biomarker Analysis 50%
• Interleukin-6 50%
• Serum Levels 50%
• Area under the Curve 50%
• Receiver Operating Characteristic 50%
• Vulnerable Plaque 50%
• Positive Predictive Value 50%
• Interleukin-1β 50%
• Early Recognition 50%
• Vulnerable People 50%
• Plaque Instability 50%
• Stroke Prevention 50%
• Multiple Biomarkers 50%
• Score Analysis 50%
• Multiple Receivers 50%
• Symptomatic Patients 50%

Medicine and Dentistry

• Biological Marker 100%
• Apoplexy 100%
• Interstitial Collagenase 50%
• Metalloprotease Inhibitor 50%
• Study Subject 50%
• Vulnerable Plaque 25%
• Tumor Necrosis Factor 25%
• Interleukin 6 25%

Immunology and Microbiology

• Tumor Necrosis Factor 100%
• Blood Level 100%
• Interleukin 6 100%